322 related articles for article (PubMed ID: 30925702)
1. PTEN as a Prognostic/Predictive Biomarker in Cancer: An Unfulfilled Promise?
Bazzichetto C; Conciatori F; Pallocca M; Falcone I; Fanciulli M; Cognetti F; Milella M; Ciuffreda L
Cancers (Basel); 2019 Mar; 11(4):. PubMed ID: 30925702
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and Predictive Implications of PTEN in Breast Cancer: Unfulfilled Promises but Intriguing Perspectives.
Carbognin L; Miglietta F; Paris I; Dieci MV
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31546901
[TBL] [Abstract][Full Text] [Related]
3. Benefit to neoadjuvant anti-human epidermal growth factor receptor 2 (HER2)-targeted therapies in HER2-positive primary breast cancer is independent of phosphatase and tensin homolog deleted from chromosome 10 (PTEN) status.
Nuciforo PG; Aura C; Holmes E; Prudkin L; Jimenez J; Martinez P; Ameels H; de la Peña L; Ellis C; Eidtmann H; Piccart-Gebhart MJ; Scaltriti M; Baselga J
Ann Oncol; 2015 Jul; 26(7):1494-500. PubMed ID: 25851628
[TBL] [Abstract][Full Text] [Related]
4. Regulation and modulation of PTEN activity.
Naderali E; Khaki AA; Rad JS; Ali-Hemmati A; Rahmati M; Charoudeh HN
Mol Biol Rep; 2018 Dec; 45(6):2869-2881. PubMed ID: 30145641
[TBL] [Abstract][Full Text] [Related]
5. PTEN: Multiple Functions in Human Malignant Tumors.
Milella M; Falcone I; Conciatori F; Cesta Incani U; Del Curatolo A; Inzerilli N; Nuzzo CM; Vaccaro V; Vari S; Cognetti F; Ciuffreda L
Front Oncol; 2015; 5():24. PubMed ID: 25763354
[TBL] [Abstract][Full Text] [Related]
6. PTEN expression and function in adult cancer stem cells and prospects for therapeutic targeting.
Ciuffreda L; Falcone I; Incani UC; Del Curatolo A; Conciatori F; Matteoni S; Vari S; Vaccaro V; Cognetti F; Milella M
Adv Biol Regul; 2014 Sep; 56():66-80. PubMed ID: 25088603
[TBL] [Abstract][Full Text] [Related]
7. Functions and Regulation of the PTEN Gene in Colorectal Cancer.
Molinari F; Frattini M
Front Oncol; 2013; 3():326. PubMed ID: 24475377
[TBL] [Abstract][Full Text] [Related]
8. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
Hales EC; Taub JW; Matherly LH
Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
[TBL] [Abstract][Full Text] [Related]
9. Pten signaling in gliomas.
Knobbe CB; Merlo A; Reifenberger G
Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
[TBL] [Abstract][Full Text] [Related]
10. Clinical implications of PTEN loss in prostate cancer.
Jamaspishvili T; Berman DM; Ross AE; Scher HI; De Marzo AM; Squire JA; Lotan TL
Nat Rev Urol; 2018 Apr; 15(4):222-234. PubMed ID: 29460925
[TBL] [Abstract][Full Text] [Related]
11. PTEN: Tumor Suppressor and Metabolic Regulator.
Chen CY; Chen J; He L; Stiles BL
Front Endocrinol (Lausanne); 2018; 9():338. PubMed ID: 30038596
[TBL] [Abstract][Full Text] [Related]
12. [Research progress of suppressor gene PTEN].
Zhao JZ; Zheng XQ; Gao M
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Oct; 51(10):797-800. PubMed ID: 27765117
[TBL] [Abstract][Full Text] [Related]
13. PTEN expression is upregulated by a RNA-binding protein RBM38 via enhancing its mRNA stability in breast cancer.
Zhou XJ; Wu J; Shi L; Li XX; Zhu L; Sun X; Qian JY; Wang Y; Wei JF; Ding Q
J Exp Clin Cancer Res; 2017 Oct; 36(1):149. PubMed ID: 29052531
[TBL] [Abstract][Full Text] [Related]
14. The PTEN tumor suppressor gene and its role in lymphoma pathogenesis.
Wang X; Huang H; Young KH
Aging (Albany NY); 2015 Dec; 7(12):1032-49. PubMed ID: 26655726
[TBL] [Abstract][Full Text] [Related]
15. PTEN/PI3K/AKT protein expression is related to clinicopathological features and prognosis in breast cancer with axillary lymph node metastases.
Wang LL; Hao S; Zhang S; Guo LJ; Hu CY; Zhang G; Gao B; Zhao JJ; Jiang Y; Tian WG; Wang J; Luo DL
Hum Pathol; 2017 Mar; 61():49-57. PubMed ID: 27864123
[TBL] [Abstract][Full Text] [Related]
16. Roles of PTEN (Phosphatase and Tensin Homolog) in gastric cancer development and progression.
Xu WT; Yang Z; Lu NH
Asian Pac J Cancer Prev; 2014; 15(1):17-24. PubMed ID: 24528021
[TBL] [Abstract][Full Text] [Related]
17. Phosphatase and tensin homolog deleted on chromosome 10 degradation induced by NEDD4 promotes acquired erlotinib resistance in non-small-cell lung cancer.
Sun H; Ma H; Wang J; Xia L; Zhu G; Wang Z; Sun J; Chen Z
Tumour Biol; 2017 Jul; 39(7):1010428317709639. PubMed ID: 28714370
[TBL] [Abstract][Full Text] [Related]
18. Pathway-based identification of biomarkers for targeted therapeutics: personalized oncology with PI3K pathway inhibitors.
Andersen JN; Sathyanarayanan S; Di Bacco A; Chi A; Zhang T; Chen AH; Dolinski B; Kraus M; Roberts B; Arthur W; Klinghoffer RA; Gargano D; Li L; Feldman I; Lynch B; Rush J; Hendrickson RC; Blume-Jensen P; Paweletz CP
Sci Transl Med; 2010 Aug; 2(43):43ra55. PubMed ID: 20686178
[TBL] [Abstract][Full Text] [Related]
19. Molecular pathways: intercellular PTEN and the potential of PTEN restoration therapy.
Hopkins BD; Parsons RE
Clin Cancer Res; 2014 Nov; 20(21):5379-83. PubMed ID: 25361917
[TBL] [Abstract][Full Text] [Related]
20. Research on miR-126 in glioma targeted regulation of PTEN/PI3K/Akt and MDM2-p53 pathways.
Chen SR; Cai WP; Dai XJ; Guo AS; Chen HP; Lin GS; Lin RS
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3461-3470. PubMed ID: 31081101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
